210 related articles for article (PubMed ID: 15143214)
1. NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling.
Ohtsuka M; Arase H; Takeuchi A; Yamasaki S; Shiina R; Suenaga T; Sakurai D; Yokosuka T; Arase N; Iwashima M; Kitamura T; Moriya H; Saito T
Proc Natl Acad Sci U S A; 2004 May; 101(21):8126-31. PubMed ID: 15143214
[TBL] [Abstract][Full Text] [Related]
2. NFAM1 Promotes Pro-Inflammatory Cytokine Production in Mouse and Human Monocytes.
Juchem KW; Gounder AP; Gao JP; Seccareccia E; Yeddula N; Huffmaster NJ; Côté-Martin A; Fogal SE; Souza D; Wang SS; Glynn ERA; Yung I; Ritchie J; Li L; Zheng J; Mbow ML; Li J; Chanda SK
Front Immunol; 2021; 12():773445. PubMed ID: 35095847
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption.
Ethiraj P; Haque IA; Alford AK; Gou W; Singh T; Sambandam Y; Hathaway-Schrader JD; Reddy SV
J Cell Biochem; 2021 Oct; 122(10):1534-1543. PubMed ID: 34228377
[TBL] [Abstract][Full Text] [Related]
4. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin/nuclear factors of activated T cells (NFAT)-activating and immunoreceptor tyrosine-based activation motif (ITAM)-containing protein (CNAIP), a novel ITAM-containing protein that activates the calcineurin/NFAT-signaling pathway.
Yang J; Hu G; Wang SW; Li Y; Martin R; Li K; Yao Z
J Biol Chem; 2003 May; 278(19):16797-801. PubMed ID: 12615919
[TBL] [Abstract][Full Text] [Related]
6. Dual requirement for the Ig alpha immunoreceptor tyrosine-based activation motif (ITAM) and a conserved non-Ig alpha ITAM tyrosine in supporting Ig alpha beta-mediated B cell development.
Pike KA; Ratcliffe MJ
J Immunol; 2005 Feb; 174(4):2012-20. PubMed ID: 15699130
[TBL] [Abstract][Full Text] [Related]
7. The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Igalpha cytoplasmic domain.
Patterson HC; Kraus M; Kim YM; Ploegh H; Rajewsky K
Immunity; 2006 Jul; 25(1):55-65. PubMed ID: 16860757
[TBL] [Abstract][Full Text] [Related]
8. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling.
Brdicka T; Imrich M; Angelisová P; Brdicková N; Horváth O; Spicka J; Hilgert I; Lusková P; Dráber P; Novák P; Engels N; Wienands J; Simeoni L; Osterreicher J; Aguado E; Malissen M; Schraven B; Horejsí V
J Exp Med; 2002 Dec; 196(12):1617-26. PubMed ID: 12486104
[TBL] [Abstract][Full Text] [Related]
9. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
[TBL] [Abstract][Full Text] [Related]
10. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
[TBL] [Abstract][Full Text] [Related]
11. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
12. Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail.
Kraus M; Pao LI; Reichlin A; Hu Y; Canono B; Cambier JC; Nussenzweig MC; Rajewsky K
J Exp Med; 2001 Aug; 194(4):455-69. PubMed ID: 11514602
[TBL] [Abstract][Full Text] [Related]
13. A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase.
Marshall AJ; Niiro H; Lerner CG; Yun TJ; Thomas S; Disteche CM; Clark EA
J Exp Med; 2000 Apr; 191(8):1319-32. PubMed ID: 10770799
[TBL] [Abstract][Full Text] [Related]
14. NFAT activating protein with ITAM motif 1 (NFAM1) is upregulated on circulating monocytes in coronary artery disease and potentially correlated with monocyte chemotaxis.
Long J; Chen J; Wang Q; Gao F; Lian M; Zhang P; Yang Y; Zhu H
Atherosclerosis; 2020 Aug; 307():39-51. PubMed ID: 32711213
[TBL] [Abstract][Full Text] [Related]
15. The CD3 gamma epsilon/delta epsilon signaling module provides normal T cell functions in the absence of the TCR zeta immunoreceptor tyrosine-based activation motifs.
Pitcher LA; Mathis MA; Young JA; DeFord LM; Purtic B; Wulfing C; van Oers NS
Eur J Immunol; 2005 Dec; 35(12):3643-54. PubMed ID: 16259006
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of immune responses by ITAM-bearing receptors.
Hamerman JA; Lanier LL
Sci STKE; 2006 Jan; 2006(320):re1. PubMed ID: 16449667
[TBL] [Abstract][Full Text] [Related]
17. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
[TBL] [Abstract][Full Text] [Related]
18. Association of signal-regulatory proteins beta with KARAP/DAP-12.
Tomasello E; Cant C; Bühring HJ; Vély F; André P; Seiffert M; Ullrich A; Vivier E
Eur J Immunol; 2000 Aug; 30(8):2147-56. PubMed ID: 10940905
[TBL] [Abstract][Full Text] [Related]
19. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation.
Rowley RB; Burkhardt AL; Chao HG; Matsueda GR; Bolen JB
J Biol Chem; 1995 May; 270(19):11590-4. PubMed ID: 7538118
[TBL] [Abstract][Full Text] [Related]
20. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.
Kanazawa N; Okazaki T; Nishimura H; Tashiro K; Inaba K; Miyachi Y
J Invest Dermatol; 2002 Feb; 118(2):261-6. PubMed ID: 11841542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
